Clinical Trial Update: A Long-term Safety Study With Tapentadol ER and Oxycodone CR in Patients With Moderate to Severe Pain Due to Chronic, Painful Diabetic Peripheral Neuropathy (DPN) [Phase 3]

View source ↗

Summary

A Phase 3 long-term safety study evaluating tapentadol ER and oxycodone CR in adults with painful diabetic polyneuropathy was terminated, with results posted Ma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Polyneuropathy
• Painful Diabetic Polyneuropathy

Drugs mentioned

• Nucynta ER (tapentadol extended-release)
• OXYCONTIN (OXYCODONE HYDROCHLORIDE)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Diabetic Neuropathy, Painful, Diabetic Polyneuropathy | Phase 3 | Status: TERMINATED | Results posted: 2011-05-10